Exact Sciences Corporation Profile Avatar - Palmy Investing

Exact Sciences Corporation

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated wit…
Medical - Diagnostics & Research
US, Madison [HQ]

Cash Flow Statements

15 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Operating Activities
Operating Cash Flow (OCF)
-12.00 -13.00 -27.00 -44.00 -39.00 -80.00 -134.00 -130.00 -71.00 -69.00 -115.00 136.00 -102.00 -223.00 156.00
Operating Cash (Net)
-12.00 -13.00 -27.00 -44.00 -39.00 -80.00 -134.00 -130.00 -71.00 -69.00 -115.00 136.00 -102.00 -223.00 156.00
Accounts Receivable
- - - - - - - - - - -1.00 -3.00 -3.00 -17.00 -17.00 -27.00 -100.00 25.00 61.00 -43.00
Accounts Payable
- - - - - - 2.00 -2.00 1.00 - - -2.00 15.00 11.00 - - 46.00 153.00 -52.00 82.00
Working Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Investing Activities
Used Cash (Net)
-2.00 -14.00 -43.00 -38.00 -35.00 -117.00 -64.00 -11.00 -160.00 -781.00 -121.00 -702.00 -1,082.00 74.00 49.00
Capital Expenditure
- - - - -2.00 - - -9.00 -12.00 -21.00 -14.00 -69.00 -150.00 -171.00 -64.00 -135.00 -214.00 -124.00
Purchases of Investments
-18.00 -24.00 -87.00 -96.00 -98.00 -209.00 -205.00 -189.00 -357.00 -1,192.00 -634.00 -1,089.00 -1,164.00 -131.00 -139.00
Sale/Maturity of Investment
16.00 10.00 46.00 58.00 72.00 104.00 162.00 193.00 271.00 579.00 1,660.00 886.00 794.00 453.00 382.00
Property, Plant, Equipment (P&PE)
- - - - -2.00 - - -9.00 -12.00 -21.00 -14.00 -69.00 -150.00 -171.00 -64.00 -135.00 -214.00 -124.00
Acquisitions (Net)
- - - - - - - - - - - - 1.00 - - -5.00 -17.00 -973.00 -22.00 -517.00 -57.00 -68.00
Other Investing Activities
- - - - - - - - - - - - -1.00 - - -109.00 -614.00 -1.00 -411.00 -58.00 24.00 - -
Financing Activities
Used Cash (Net)
-32.00 -85.00 -27.00 -60.00 -74.00 -244.00 -181.00 -149.00 -260.00 -934.00 -253.00 -1,879.00 -8.00 -76.00 -159.00
Debt Repayment
- - - - - - - - - - - - - - - - - - -4.00 -236.00 -150.00 -23.00 -50.00 -137.00
Dividends Paid
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Common Stock
- - - - - - - - - - 237 172 - - - - - - - - 843 14 -18 3
Other Financing Activities
18.00 2.00 - - 2.00 75.00 5.00 8.00 149.00 261.00 1,859.00 17.00 1,167.00 9.00 44.00 21.00
Cash Balances
Begin of Period
4.00 21.00 78.00 35.00 13.00 12.00 58.00 41.00 48.00 77.00 160.00 177.00 1,491.00 315.00 242.00
End of Period
21.00 78.00 35.00 13.00 12.00 58.00 41.00 48.00 77.00 160.00 177.00 1,491.00 315.00 242.00 609.00
Change
16.00 56.00 -42.00 -22.00 - - 45.00 -16.00 7.00 28.00 82.00 17.00 1,314.00 -1,175.00 -72.00 366.00
Non-Cash Balances
Depreciation and Amortization
- - - - - - - - 1.00 3.00 7.00 11.00 15.00 23.00 50.00 163.00 180.00 197.00 206.00
Stock Based Compensation
2.00 2.00 4.00 5.00 7.00 11.00 18.00 23.00 35.00 - - 108.00 152.00 253.00 206.00 231.00
Other
1.00 - - -28.00 -2.00 -4.00 - - - - - - - - 26.00 48.00 721.00 202.00 33.00 -76.00
Highlighted metrics
Free Cash Flow (FCF)
-13.00 -14.00 -29.00 -44.00 -48.00 -93.00 -156.00 -144.00 -140.00 -219.00 -286.00 72.00 -238.00 -438.00 31.00
Cash Conversion Cycle (CCC)
-2,828.00 -15,634.00 -11,634.00 - - - - 394.00 95.00 80.00 81.00 69.00 114.00 115.00 74.00 55.00 56.00
Invested Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Operating Inflows/Outflows
End of EXAS's Analysis
CIK: 1124140 CUSIP: 30063P105 ISIN: US30063P1057 LEI: - UEI: -
Secondary Listings
EXAS has no secondary listings inside our databases.